Anne Szustek Deals of the Year 2014: Actavis Realizes Bigger Pharma Ambitions For CEO Brenton Saunders, the $66 billion friendly takeover of Allergan is just the latest in a string of health care mergers. Anne Szustek December 10, 2014 Jason Alden